BAM
MDXG icon

Blueshift Asset Management’s MiMedx Group MDXG Stock Holding History

Blueshift Asset Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,318
Closed -$159K – 1081
2021
Q3 		$159K Buy
+26,318
New +$297K 0.01% 942

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Blueshift Asset Management's MDXG Position: Q4 2021 in Review

Blueshift Asset Management sold out of MiMedx Group (MDXG) in Q4 2021, closing a stake of 26,318 shares — an estimated $159K sold.

Blueshift Asset Management first reported a position in MDXG in Q3 2021 and held it in 1 quarter. The position peaked at $159K in Q3 2021. 152 funds tracked by Wall St. Rank hold MDXG as of Q4 2021.

  • Blueshift Asset Management reported no remaining MiMedx Group position as of Q4 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 26,318 MiMedx Group shares in Q4 2021, an estimated $159K.
  • Blueshift Asset Management first reported a position in MiMedx Group in Q3 2021 and held it in 1 quarter.
  • Blueshift Asset Management's MiMedx Group position peaked at $159K in Q3 2021.
  • 152 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.